Click to cancel search
Login
Sign Up
Home Page
How It Works
Our Story
Symptom Checker
Second Opinion Finder
Newsroom
Partner With Us
MediFind Pro
FAQ
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
Submit Feedback
Advertising Policy
Privacy Policy
Terms & Conditions
Condition
Condition
Doctor
Symptom
Condition
Click to search for condition or expert
Login
Sign Up
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Adrenoleukodystrophy
Overview
Condition 101
Find a Doctor
Latest Research
Clinical Trials
Active Clinical Trials
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
50
Start Date:
August 20, 2020
A Prospective Outcomes Study of Pediatric and Adult Patients With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation With a Reduced-Intensity Conditioning Regimen (PRO-RIC)
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
13
Start Date:
September 13, 2019
An Open-label, Multicenter Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)
Clinical Trial
Other
Status:
Active, not recruiting
Study Type:
Other
Participants:
3
Start Date:
May 21, 2019
A Follow-Up Study to Evaluate the Safety and Clinical Outcomes of Patients With Non-Malignant Disease Who Have Undergone Hematopoietic Stem Cell Transplantation With MGTA-456
Clinical Trial
Other
Status:
Recruiting
Study Type:
Other
Participants:
1000
Start Date:
May 1, 2019
Adrenoleukodystrophy National Registry Study
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
35
Start Date:
January 24, 2019
A Phase 3 Study of Lenti-D Drug Product After Myeloablative Conditioning Using Busulfan and Fludarabine in Subjects ≤17 Years of Age With Cerebral Adrenoleukodystrophy (CALD)
Clinical Trial
Other
Status:
Recruiting
Participants:
60
Start Date:
December 17, 2018
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases
Clinical Trial
Genetic
Status:
Recruiting
Study Type:
Genetic
Participants:
10
Start Date:
October 30, 2018
Lentiviral Gene Therapy for X-linked Adrenoleukodystrophy (X-ALD)
Clinical Trial
Other
Status:
Recruiting
Participants:
100
Start Date:
February 16, 2018
A Non-interventional Study to Prospectively Assess Baseline Status and Disease Progression in Male Children With X-Linked Adrenoleukodystrophy
Clinical Trial
Drug
Status:
Active, not recruiting
Study Type:
Drug
Participants:
8
Start Date:
February 9, 2018
A Phase 2, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of MGTA-456 in Patients With Inherited Metabolic Disorders (IMD) Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Clinical Trial
Drug
Status:
Active, not recruiting
Study Type:
Drug
Participants:
105
Start Date:
December 8, 2017
A Randomized, Double-blind, Placebo-controlled, Multinational, Multicenter Study With Open-label Treatment Extension to Assess the Effect of MIN-102 (IMP) on the Progression of Adrenomyeloneuropathy in Male Patients With X-linked Adrenoleukodystrophy
Clinical Trial
Dietary Supplement
Status:
Active, not recruiting
Study Type:
Dietary Supplement
Participants:
21
Start Date:
March 2016
A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy
Clinical Trial
Genetic
Status:
Recruiting
Study Type:
Genetic
Participants:
50
Start Date:
January 2015
A Phase I/II Clinical Trial of Lentiviral Hematopoietic Stem Cell Gene Therapy for Treatment of Developed Metachromatic Leukodystrophy and Adrenoleukodystrophy
